SCHEMBL7102292

SCHEMBL7102292

Cc1ccc(-c2ccccc2C(=O)N(C)N)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
ALDH1A1 P00352 1/20 0.49
BCAT2 O15382 1/20 0.44
TACR1 P25103 2/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
LTB4R2 Q9NPC1 2/20 0.41
SLC6A3 Q01959 3/20 0.41
SLC6A4 P31645 2/20 0.41
GAA P10253 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7016782 0.80 KMT2A (0.50) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL6004326 0.79 BCAT2 (0.71) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL14134245 0.79 KEAP1 (0.54) KMT2AMEN1SMN1; SMN2ALDH1A1MAPT
SCHEMBL7374560 0.78 KMT2A (0.58) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL16882044 0.78 KMT2A (0.48) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL7745951 0.77 CHEK1 (0.49) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL372 0.77 KMT2A (0.60) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL31402608 0.77 KMT2A (0.60) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2
SCHEMBL13845096 0.76 HDAC7 (0.66) SMN1; SMN2ALDH1A1LMNASLC6A3SLC6A4
Hydrochloric Acid SCHEMBL7610390 0.75 KMT2A (0.59) KMT2AMEN1SMN1; SMN2ALDH1A1BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5736555-A HYPOTENSIVE AGENTS; FDA ORANGE BOOK LISTED PATENT FOR AZILSARTAN MEDOXOMIL TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-07 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed